23andMe Can Be The Next Big Thing In Biopharma

Startup company 23andMe looks set to gain prominence in the biotech sector by partnering with major pharmaceuticals like Pfizer and Johnson & Johnson for groundbreaking research on inflammatory bowel diseases Mountain View, California-based startup 23andMe is partnering up with drug…

StocksBeat

Democratizing access to all financial data. Cutting edge web platform for news and information.

Disclaimer: StocksBeat inform you that the data in this website is not necessarily real-time nor accurate. All prices are not provided by exchanges and prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Stocksbeat doesn`t bear any responsibility for any trading losses you might incur as a result of using the data.

Subscribe